Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Oct 31;6(1):62.
doi: 10.1186/s41927-022-00294-8.

Fibromyalgia: epidemiology and risk factors, a population-based case-control study in Damascus, Syria

Affiliations

Fibromyalgia: epidemiology and risk factors, a population-based case-control study in Damascus, Syria

Mhd Amin Alzabibi et al. BMC Rheumatol. .

Abstract

Background: Fibromyalgia is a chronic disease with a high burden. We aim to be the first to investigate the prevalence of fibromyalgia (FM) in Syria and assess its risk factors.

Methods: A self-reported questionnaire was distributed to the public to identify fibromyalgia patients using the American College of Rheumatology (ACR) 2010 modified criteria. Identified cases were matched using age with controls free from rheumatic disorders that were randomly sampled from the same population.

Results: Out of 2966 participants, 350 (11.8%) satisfied the diagnostic criteria. Of these, only 29 (8.2%) were previously diagnosed by a physician, 239 (68.3%) were females, and 69 (19.71%) were diagnosed with depression. Female sex (OR = 1.31), diagnosis of major depressive disorder (OR = 2.62), irritable bowel syndrome (OR = 1.8), and Restless legs syndrome (OR = 1.72) were associated with a higher likelihood of fibromyalgia.

Conclusion: Our study revealed one of the highest prevalence rates of fibromyalgia ever reported in the general population. Efforts must be intensified to increase awareness about this disease in Syrian society as well as among healthcare providers.

Keywords: Epidemiology; Fibromyalgia; Prevalence.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

References

    1. Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P, Russell AS, Russell IJ, Winfield JB, Yunus MB. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthr Care Res. 2010;62(5):600–610. doi: 10.1002/acr.20140. - DOI - PubMed
    1. Bair MJ, Krebs EE. Fibromyalgia. Annals of internal medicine. 2020;172(5):33–48. doi: 10.7326/AITC202003030. - DOI - PubMed
    1. Trouvin AP, Perrot S. New concepts of pain. Best Pract Res Clin Rheumatol. 2019;33(3):101415. doi: 10.1016/j.berh.2019.04.007. - DOI - PubMed
    1. Schmidt-Wilcke T, Clauw DJ. Fibromyalgia: from pathophysiology to therapy. Nat Rev Rheumatol. 2011;7(9):518–527. doi: 10.1038/nrrheum.2011.98. - DOI - PubMed
    1. Løge-Hagen JS, Sæle A, Juhl C, Bech P, Stenager E, Mellentin AI. Prevalence of depressive disorder among patients with fibromyalgia: Systematic review and meta-analysis. J Affect Disord. 2019;245:1098–1105. doi: 10.1016/j.jad.2018.12.001. - DOI - PubMed

LinkOut - more resources